Wall Street analysts expect Envision Healthcare Co. (NYSE:EVHC) to report earnings per share of $0.57 for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Envision Healthcare’s earnings, with the highest EPS estimate coming in at $0.99 and the lowest estimate coming in at $0.45. Envision Healthcare reported earnings of $1.15 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 50.4%. The business is expected to announce its next earnings results on Tuesday, February 27th.

On average, analysts expect that Envision Healthcare will report full-year earnings of $2.85 per share for the current year, with EPS estimates ranging from $2.68 to $3.39. For the next financial year, analysts expect that the business will report earnings of $3.19 per share, with EPS estimates ranging from $2.54 to $3.80. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that follow Envision Healthcare.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. During the same quarter last year, the firm posted $1.13 earnings per share. Envision Healthcare’s revenue was up 142.0% compared to the same quarter last year.

A number of research firms recently issued reports on EVHC. Zacks Investment Research upgraded Envision Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Mizuho reduced their price objective on Envision Healthcare from $65.00 to $57.00 and set a “neutral” rating for the company in a research report on Wednesday, August 9th. Robert W. Baird reduced their price objective on Envision Healthcare from $70.00 to $35.00 and set an “outperform” rating for the company in a research report on Friday, November 3rd. BidaskClub lowered Envision Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 17th. Finally, Oppenheimer reduced their price objective on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating for the company in a research report on Thursday, November 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $47.57.

A number of hedge funds have recently made changes to their positions in EVHC. Commonwealth Bank of Australia boosted its position in Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after acquiring an additional 410 shares during the period. LMR Partners LLP acquired a new position in Envision Healthcare during the 2nd quarter worth $205,000. Palisade Capital Management LLC NJ acquired a new position in Envision Healthcare during the 3rd quarter worth $229,000. Cutter & CO Brokerage Inc. boosted its position in Envision Healthcare by 11.1% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after acquiring an additional 367 shares during the period. Finally, Flinton Capital Management LLC boosted its position in Envision Healthcare by 18.7% during the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after acquiring an additional 704 shares during the period.

Envision Healthcare (NYSE EVHC) traded up $0.40 during trading hours on Tuesday, reaching $31.23. The company had a trading volume of 2,627,090 shares, compared to its average volume of 2,237,490. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $74.19. The firm has a market cap of $3,730.00, a price-to-earnings ratio of 9.49, a P/E/G ratio of 0.80 and a beta of 0.57. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89.

Envision Healthcare declared that its Board of Directors has initiated a share buyback program on Monday, September 18th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the company to buy up to 4.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “$0.57 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/05/0-57-eps-expected-for-envision-healthcare-co-evhc-this-quarter.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Get a free copy of the Zacks research report on Envision Healthcare (EVHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.